Come up with a name for your new list and we'll add to it:
Ziarco Pharma was acquired by
Novartis on December 16, 2016.
Ziarco is a dermatology therapeutics firm that develops a range of oral and topical products for the treatment of atopic dermatitis and psoriasis. Ziarco's lead candidate, ZPL-389, is a once-daily ora…